Hilltop Holdings’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Hilltop Holdings’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-21,360	Closed	-$406K	–	464
2018 Q1	$406K	Buy	+21,360	New	+$457K	0.07%	259

Other funds holding SGMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Hilltop Holdings's SGMO Position: Q2 2018 in Review

Hilltop Holdings sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2018, closing a stake of 21,360 shares — an estimated $406K sold.

Hilltop Holdings first reported a position in SGMO in Q1 2018 and held it in 1 quarter. The position peaked at $406K in Q1 2018. 210 funds tracked by Wall St. Rank hold SGMO as of Q2 2018.

Hilltop Holdings reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2018 after selling out during the quarter.
Hilltop Holdings sold 21,360 SANGAMO THERAPEUTICS INC shares in Q2 2018, an estimated $406K.
Hilltop Holdings first reported a position in SANGAMO THERAPEUTICS INC in Q1 2018 and held it in 1 quarter.
Hilltop Holdings's SANGAMO THERAPEUTICS INC position peaked at $406K in Q1 2018.
210 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2018.

Based on Hilltop Holdings's 13F filing for Q2 2018, filed 14 Aug 2018.